Dr. Kaveh Rezaei Bookani, MD

Dr. Rezaei Bookani practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Rezaei Bookani's NPI, 1477904829, was assigned on June 28, 2016. Dr. Rezaei Bookani holds Illinois license 125073501.

Dr. Rezaei Bookani's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Rezaei Bookani also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Rezaei Bookani's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Rezaei Bookani is also affiliated with CHI Health Lakeside. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Rezaei Bookani to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rezaei Bookani practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rezaei Bookani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rezaei Bookani is licensed in Illinois.

CMS data shows 1,598 Medicare services from Dr. Rezaei Bookani across 17 procedure codes in 2024, for 820 Medicare patients. Medicare paid $59,848 for them.

CMS counts 820 Medicare patients who saw Dr. Rezaei Bookani in 2024. The largest group is 65 to 74, with 384 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rezaei Bookani's median patient age at 72, with 45% women.

In 2024, Dr. Rezaei Bookani wrote 821 Medicare Part D claims for 146 patients. 84% of them were for generic drugs. CMS names the drug for 719 of them, across 20 drugs with 11 or more claims each, at $146,928 in total drug cost. In 2023, CMS named 60 claims across 3 drugs.

Dr. Rezaei Bookani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Rezaei Bookani, published from 2017 to 2022. 2022 was the busiest year, with 2. Dr. Rezaei Bookani's most frequent co-authors are Iva Minga, MD, Alfonso Javier Tafur, MD and Ashley Elizabeth Aller, MD.

CMS Open Payments shows 36 general payments to Dr. Rezaei Bookani from 11 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 58% of the total. HeartFlow, Inc. paid the most, $1,421.